Abstract
Long-lived proteins are subject to spontaneous degradation and may accumulate a range of modifications over time, including subtle alterations such as side-chain isomerization. Recently, tandem MS has enabled identification and characterization of such peptide isomers, including those differing only in chirality. However, the structural and functional consequences of these perturbations remain largely unexplored. Here, we examined the impact of isomerization of aspartic acid or epimerization of serine at four sites mapping to crucial oligomeric interfaces in human αA- and αB-crystallin, the most abundant chaperone proteins in the eye lens. To characterize the effect of isomerization on quaternary assembly, we utilized synthetic peptide mimics, enzyme assays, molecular dynamics calculations, and native MS experiments. The oligomerization of recombinant forms of αA- and αB-crystallin that mimic isomerized residues deviated from native behavior in all cases. Isomerization also perturbs recognition of peptide substrates, either enhancing or inhibiting kinase activity. Specifically, epimerization of serine (αASer-162) dramatically weakened inter-subunit binding. Furthermore, phosphorylation of αBSer-59, known to play an important regulatory role in oligomerization, was severely inhibited by serine epimerization and altered by isomerization of nearby αBAsp-62. Similarly, isomerization of αBAsp-109 disrupted a vital salt bridge with αBArg-120, a contact that when broken has previously been shown to yield aberrant oligomerization and aggregation in several disease-associated variants. Our results illustrate how isomerization of amino acid residues, which may seem to be only a minor structural perturbation, can disrupt native structural interactions with profound consequences for protein assembly and activity.
Keywords: aging, mass spectrometry (MS), radical, chaperone, protein structure, protein self-assembly, protein phosphorylation, protein chemical modification, molecular dynamics, epimer
Introduction
Long-lived proteins are important but often underappreciated, with recent findings illustrating their pervasiveness within critical organs and suggesting that their chemistry and biology should not be ignored (1, 2). Longevity renders proteins susceptible to degradation via nonenzymatic, spontaneous chemical modifications, including truncation, cross-linking, oxidation, deamidation, isomerization, and epimerization (1, 3). Aspartic acid residues are most prone to isomerization (4), readily forming a succinimide ring following attack of the side chain by the peptide backbone. The succinimide is susceptible to racemization and can reopen in two ways, ultimately yielding four isomers: l-Asp, d-Asp, l-isoAsp, and d-isoAsp (5). The time scale for this process is likely dependent on many factors and will vary for each protein, but knockout experiments in mice have demonstrated that absence of the repair enzyme that targets l-isoAsp leads to fatal consequences within 4–6 weeks (6, 7).
Deamidation of asparagine can also yield four isomers of aspartic acid, but this process involves chemical substitution in addition to isomerization. Aspartic acid isomerization is one of the most prevalent degradation pathways of crystallin proteins in aged human lenses and is known to increase with age. Serine is also frequently found to undergo isomerization in long-lived proteins; this localized chiral inversion, known as epimerization, produces d-Ser (4, 8). Isomerization and epimerization (illustrative examples shown in Fig. 1) are difficult to detect because they do not lead to a change in mass and are consequently invisible to mass spectrometry (MS)-based methods typically employed during proteomic analyses (9, 10). As a result, they are not widely studied and are frequently overlooked, and their consequences at the molecular level are largely unknown. Among the few previously reported examples, a study of hen egg white lysozyme with an l-isoAsp substitution at Asp-101 caused a backbone deflection of nearly 90° relative to the native structure (11), and l-isoAsp-32 insertion into RNase forms a protruding U-shaped loop bent by nearly 90° instead of an α-helix (12). Isomerization can also affect physical properties such as solubility and bioactivity, with isomerization of Asp-92 in immunoglobulin γ2 (IgG2) leading to deactivation of the antigen-binding region (13).
The crystallin proteins of the eye lens, in which there is no protein turnover, are among the longest-lived proteins in the body (14). They are ideal targets for studying spontaneous degradation pathways that occur due to aging, and experiments have previously revealed that isomerization compromises water solubility and oligomerization (15–18). The most abundant crystallins in humans, αA and αB, are important molecular chaperone (19) and regulatory proteins (20). Although αA is localized almost exclusively to the eye lens (21), αB is found throughout the body (22, 23). Crystallin malfunction due to mutation or accumulation of PTMs4 is associated with a variety of diseases, including cataract, cardiomyopathies, motor neuropathies, and neurodegeneration (3, 24, 25).
αA and αB are members of the small heat-shock protein family (19), with structures characterized by a highly conserved α-crystallin domain (26) flanked in both proteins by less ordered N- and C-terminal regions (Fig. 2A). Outside of the α-crystallin domain, αA and αB share only modest sequence homology (21). Despite this, αA and αB self- and co-assemble into large, polydisperse, and dynamic oligomers. A number of interfaces mediate this oligomerization, which begins with dimerization between pairs of ordered α-crystallin domains. The dimers then associate into oligomers via an interface between a palindromic sequence in the C-terminal region of one dimer and the α-crystallin domain of another, as well as interactions involving N-terminal regions (Fig. 2B) (27–29). Perturbation of the dimer interface, as occurs in the well-known R120G variant of αB (30) or mutations in the terminal regions, can lead to protein aggregation and malfunction (31). The chaperone capacity and localization of αB are also partially regulated by phosphorylation of three serines in the N-terminal region, with dysregulation leading to disease (32–36).
We recently reported 81 sites of isomerization in human αA and αB isolated from the eye lenses of aged donors (17). Here, we examine the structural consequences of isomerization at four of these sites that reside in regions critical for oligomerization, and our experiments demonstrate how key structural interactions or functionality are disrupted by isomerization. Native MS (37, 38) in conjunction with synthetic isomers, enzymatic assays, and molecular dynamics (MD) simulations were used to probe the structural consequences. Our results demonstrate that age-related isomerization of individual amino acid residues can have significant impact on the quaternary structure and function of α-crystallins, and they suggest that similar “invisible” PTMs in other long-lived proteins may have important influences on age-related diseases.
Results and discussion
αA and αB accumulate isomeric PTMs at their interfaces
The structures of the α-crystallin domains of αA- and αB-crystallin are very similar. Therefore, to orient where sites of interest reside in both proteins, the α-crystallin domain of αB is used as a representative model in Fig. 2A. In the process of oligomeric assembly, monomers first come together to form dimers. As seen in Fig. 2A, left, the dimer interface is defined by an anti-parallel β-sheet formed by the same sequence region from two different monomers. Hydrogen bonding along the intermolecular β-sheet and two complementary Arg-120–Asp-109 salt bridges stabilize the interface. Another crucial interaction occurs in a groove where the normally disordered C-terminal tail can bind (Fig. 2A, right). This interface is one of several that facilitates the assembly of dimers into larger oligomers. The disordered N-terminal tail also forms quaternary interactions favoring oligomerization in the general region shown in Fig. 2A, left, although the interaction partners are omitted for clarity. All of these regions are critical for proper crystallin assembly and function, suggesting that structural perturbations within these interfaces could have undesirable consequences.
Previous analysis identified (17) (without detailed study) four sites of isomerization within these regions. Given the potential structural impact, we now examine these sites in detail. Identification of isomerization and epimerization first requires proteolysis. Tryptic digestion of the crystallins yields three peptides that contain the four sites of interest (underlined): αA-158AIPVSR163, which lies in the C-terminal region; αB-57APSWFDTGLSEMR69, which encompasses residues involved in an N-terminal interface; and αB-108QDEHGFISR116, which lies in the α-crystallin domain at the dimer interface. Each of these peptides corresponds to one of the pink regions in Fig. 2A. The degree of isomerization or epimerization at each site was determined with RDD-MS, as described in detail previously (17), and the results are shown in Fig. 2, B–E and Tables S1–S4. These data were obtained from the nucleus and cortex of a 72-year-old human lens, although the results are similar to those from younger donor lenses (data not shown). The complete crystallin sequences, including all known isomerized and epimerized residues, are listed for reference in Fig. S1 along with additional details about isomer identification in Fig. S2.
RDD-MS results for αA-158AIPVSR163 are shown in Fig. 2B. The ratio of the product ions at 350.25z and 364.00 m/z varies with elution time across the chromatographic peak for the water-insoluble (WI) fraction (compare the red and black rear mass spectra in Fig. 2B). In contrast, the RDD spectra for the water-soluble (WS) fraction do not vary as a function of retention time, as shown in the forward mass spectra of Fig. 2B. The WS spectra both match RDD data obtained from a synthetic l-Ser isomer. The changing product ion ratios for the WI fraction are meaningful because the radical in RDD is created photolytically (39) at a single, atomically precise location in both isomers. Subsequent collisional activation stimulates migration of the radical and fragmentation of the peptide. Differences in three-dimensional structure due to isomerization therefore lead to differences in radical migration, which impacts the abundance of certain fragment ions. Therefore, the varying product ion ratios for the WI fraction in Fig. 2B reveal isomerization of the peptide, even though this modification is not readily apparent by chromatography. Further analysis with synthetic standards confirms epimerization at αASer-162 and enables quantification of the abundance of αAd-Ser-162 at 8% (see Fig. 3 for details) (40). The similarity of RDD spectra across the WS peak indicates absence of isomerization in that fraction. Variations in the relative abundance between the WI/WS fractions may correlate with perturbed oligomerization, as discussed in more detail below.
This approach can also be applied to more complex systems, as illustrated by the chromatograms for separation of αB-57APSWFDTGLSEMR69, from which nine different isomers were identified in the WI fraction (Fig. 2C, bottom). Synthetic standards of selected candidates were used to determine that the original all-l peptide comprises only 14% of the total abundance in the WI fraction (peak 7, which dominates the WS fraction). The αBd-Ser-59 epimer is present in 5.6% abundance (peak 4) in the WI fraction and 1.4% in the WS fraction (see Fig. S3 for more information). Interestingly, when αB-57APSWFDTGLSEMR69 is phosphorylated at αBSer-59, only a single isomer is detected in the WS fraction (Fig. 2D), and a small number of isomers are detected in the WI fraction. This suggests that there is a relationship between phosphorylation and isomerization. Finally, the WS and WI fractions of αB-108QDEHGFISR116 both contain multiple isomers of αBAsp-109 (Fig. 2E), but the relative abundance of αBl-isoAsp-109 increases from 5.1 to 55.4% in the WI portion. This dramatic difference may suggest that isomerization of αBAsp-109 influences aggregation propensity. Upon detailed examination, it is clear that isomerization and epimerization are occurring in regions known to be critical for the proper function and assembly of the α-crystallins. Furthermore, these results hint at structural consequences (as suggested previously in relation to observations of aggregation (16, 17)), but more detailed investigation is required to reveal how these modifications exert structural influence at the molecular level.
Epimerization of the C-terminal region compromises binding to α-crystallin domain
Ser-162 from αA is an epimerized residue located adjacent to the highly conserved palindromic IX(I/V) motif within the C-terminal region that binds to a groove in the α-crystallin domain (Fig. 2A). Examination of the available crystal structures (Fig. 4A) reveals that the C-terminal tail can occupy the groove in the β8 → β4 direction or the inverse direction (β4 → β8), stabilized by hydrogen bonding between the peptide backbones in either case (41). Although the binding to this groove is dynamic and can occur through two different states, these interactions are crucial for proper oligomerization, and prior work has shown that point mutations can influence the kinetics and thermodynamics of assembly (42).
To quantify the effect of αBSer-162 epimerization on binding within this groove, we conducted a series of native MS experiments similar to previous work examining interactions between the α-crystallin core domain and peptide portions of the C-terminal tail (42). This native MS approach shows excellent agreement with NMR-based titrations (43), with the added benefit of being able to accommodate the heterogeneity of the system that other methods average over. The core domains, when analyzed alone, yield peaks corresponding to monomer (αA) and both monomer and dimer (αB) (Fig. 4, B and C, lower spectra). This suggests that the αA dimer interface is slightly weaker than that of αB, although the native dimer complex can be preserved and detected with native MS for both proteins. Competition binding experiments between the α-crystallin domain and palindromic peptides containing either d- or l-Ser-162 are shown in the middle and upper mass spectra of Fig. 4, B and C, and summarized in D. The canonical all l-amino acid form of the peptide, ERAIPVSRE, and a d-isomer variant made distinguishable by addition of glycine to both termini, GERAIPVSREG (S = d-Ser), were added at a 4:1 peptide/α-crystallin domain molar ratio. The dominant adduct observed corresponds to the binding of the canonical peptide, with the d-isomer representing only a small fraction of the binding (Fig. 4D).
To eliminate the possibility that the additional glycine residues might be responsible for the difference in binding, the inverse experiment was conducted with the appended-glycine l-isomer (Fig. 4, B and C, and insets, upper spectra). Binding of the l-isomer dominates again in both systems (Fig. 4D), and the data can be used for quantification (44, see Table S5) of the dissociation constants: αA core l-Ser = 48 μm, αB core l-Ser = 115 μm, αA core d-Ser = 650 μm, and αB core d-Ser = 1380 μm. Based on these values, epimerization leads to destabilization of ΔΔG = ∼6 kJ/mol. All of these results are consistent with d-αASer-162 significantly inhibiting proper interaction between the C-terminal palindrome and the β4–β8 groove in the α-crystallin domain.
We have previously shown that removal of the side chain at the equivalent position in αB (αBT162A) leads to a weaker interaction in the peptide–α-crystallin domain system and faster subunit-exchange of full-length αB (42). The present data suggest that epimerization of αASer-162 similarly weakens binding, which would also be expected to perturb the dynamics and chaperone activity of αA. Furthermore, because the diversity of binding modes between the C-terminal tail and the α-crystallin domain promotes polydispersity and aids in preventing crystallization (41), disruption of this binding may lead to increased oligomerization and explain the high abundance of the isomerized peptide in the WI lens fraction. Because both chaperone activity and polydispersity are presumed to help maintain lens transparency (31, 45), epimerization of αASer-162 is a likely contributor to age-related protein aggregation within the lens.
Phosphorylation is precluded by epimerization of αBSer-59 and affected by isomerization of αBAsp-62
Many observations suggest that αBSer-59 is a structurally important site, including solid-state NMR data showing αBSer-59 is involved in various inter-monomer contacts (46). As illustrated in Fig. 2C, the peptide containing αBSer-59 and αBAsp-62 is highly isomerized in a normal lens. In addition, the degree of epimerization at Ser-59 increases in cataractous lenses (8). Ser-59 is also a primary site of phosphorylation in αB, which helps regulate oligomeric size and activity (47). However, within the lens phosphorylation is primarily observed in the younger cortex (48).
To investigate the influence of αBSer-59 epimerization and αBAsp-62 isomerization on phosphorylation, we incubated the corresponding synthetic isomers of FLRAPSWFDTG-NH2 with the native kinase, MAPKAPK-2 (49). The extracted ion chromatograms for both peptides reveal that the ratio of l-/d-Ser-59 phosphorylation is ∼240:1 after 2 h and ∼350:1 after 12 h of incubation (Fig. 5, A and B), indicating that the d-Ser-59 isomer is a poor substrate for the kinase. Interestingly, examination of the phosphorylated peptide in the lens reveals only minor isomerization (Fig. 2D), offering sharp contrast to the abundant isomerization of the unmodified peptide. This suggests that modifications elsewhere on the peptide may also inhibit phosphorylation, or that phosphorylation prevents isomerization, or both. Additional in vitro experiments confirmed that phosphorylation is inhibited by d-isoAsp-62, but slightly enhanced by d-Asp or l-isoAsp at the same position (Fig. 5B). In sum, the native kinase activity is affected by all three non-native Asp isomers and essentially prevented by epimerization of Ser. These results provide a potential explanation for previous experiments that failed to isolate phosphorylated d-Ser from erythrocytes (50).
Ser-59 and Asp-62 have also been suggested to be involved in an interfacial salt-bridge cluster with Arg-163 and Glu-165 of an adjacent monomer (51). In this model, all four residues are in close proximity, with isomerization of Asp-62 or Ser-59 both likely to perturb the dynamics of the salt bridge and disrupt the interface (Fig. 5C). Similarly, phosphorylation of Ser-59, which resides 2.4 Å (O–O distance) from Asp-62, is likely to disrupt this salt bridge network and may account for the reduced oligomer size observed for phosphorylation mimics of Ser-59 (52). Disruption of this salt-bridge cluster is explored further in experiments with recombinant proteins below.
Isomerization of αBAsp-109 breaks dimer-stabilizing salt bridge and leads to insolubility
Fig. 2E illustrates abundant isomerization of αBAsp-109, which is known to form an inter-monomer salt bridge with αBArg-120 in the APII register (41, 46, 53), the most populated state in solution (54). Mutation at either site in the salt bridge frequently leads to malfunction and disease (53–56). For example, the R120G mutant is genetically linked to desmin-related myopathy (57), whereas mutation of αBAsp-109 is associated with myofibrillar myopathy (58) and cardiomyopathy (59). To probe the structural consequences of αBAsp-109 isomerization on the dimer interface of αB, in silico mutation and MD simulations were utilized.
The results obtained from all-atom simulations extending >150 ns are illustrated in Fig. 6. The Asp-109–Arg-120 salt bridge is stable for the l-Asp isomer, with a mean acceptor–to–donor hydrogen bond distance under 2 Å (Fig. 6A, left). For all other isomers, d-Asp-109, l-isoAsp-109, or d-isoAsp-109, the salt bridge with Arg-120 is disrupted, and the average distances increase significantly (Fig. 6A, left). To determine the influence of Asp isomerization on the stability of the dimer interface, we monitored the distances between the final backbone hydrogen bond partners (His-111 and Arg-123). Reasonable hydrogen bond distances are only maintained for the l-Asp isomer, with all other isomers producing elongated distances (Fig. 6A, right). These results are illustrated by structural snapshots in Fig. 6B. For the l-Asp isomer (upper left), a backbone hydrogen bond between His-111 and Arg-123 links together the ends of β6 + 7 strands. For the other three isomers, these partners have been shifted to noninteracting distances due to disruption of the β-sheet dimer interface. It should be emphasized that these simulations model only one of two identical salt bridges that stabilize the dimer interface. In the situation where two modified residues occupied both ends of the dimer interface, the resulting destabilization would be expected to be significantly worse. The results from these simulations offer an explanation for the observed partitioning of each isomer extracted from the lens in Fig. 2E. Specifically, the abundance of isomerized Asp-109 residues is much higher in the WI fraction, whereas l-Asp-109 is the virtually the only isomer present in the WS fraction, suggesting a single isomerization event at Asp-109 is sufficient to drive insolubility. The isomerization-induced loss of the dimer interface mimics the effects of the R120G mutation, which is known to cause protein aggregation (56) and increase the diversity of conformational states (60).
Mimicking breakage of interfacial bonds by isomerization leads to aberrant oligomerization
Our examination of the amino acid environment around both Ser-59 and Asp-109 revealed that in both cases modification at these sites would be likely to impact oligomerization. Specifically, we noted that αBSer-59 appears to be part of a network of salt bridges, which is unlikely to accommodate a bulky negative charge without significant rearrangement (Fig. 5C, above). To test this prediction, we generated the phosphorylation mimic in which αBSer-59 was mutated to Asp (αBS59D) and compared it to the WT with native MS. Both proteins gave mass spectra featuring a broad region of signal at high m/z, indicative of a polydisperse ensemble of oligomers and consistent with previous spectra of αB (Fig. 7A) (61). Notably, the signal is at slightly lower m/z values for the phosphomimic, consistent with a shift to smaller stoichiometries. To quantify this change, we performed collisional activation to remove highly charged monomers from the parent oligomers, resulting in lower “charge-stripped” oligomers that are well resolved and can be deconvolved into an oligomeric distribution (Fig. 7, B and C) that faithfully reproduces the distribution present in solution (27, 61, 62). S59D yields a distribution centered on an 18-mer, smaller than the WT, and with a stronger preference for oligomers with an even number of subunits (Fig. 7C). This suggests that phosphorylation of Ser-59, which regulates activity and localization of αB (47), leads to destabilization of the larger oligomers, likely at inter-dimer interfaces involving the N-terminal region. Similarly, isomerization of Ser-59 or Asp-62 would also be expected to disrupt the salt-bridge chain in Fig. 5C and impact oligomerization in a comparable fashion. Generally, previous results have found that phosphorylation at Ser-59 increases chaperone activity, suggesting that larger oligomers serve to “store” chaperone capacity that can be released on demand (35, 47, 63). Isomerization at Ser-59 or Asp-62 would also interfere with this regulation mechanism.
Although the S59D mutant is an effective mimic of phosphorylated Ser-59, direct probing of the structural impacts of isomerization and epimerization is more problematic. It is not possible to use site-directed mutagenesis to insert d-residues or isoAsp into proteins, nor, given that both modifications are spontaneous, is it feasible to induce isomerization or epimerization in a site-specific and controllable fashion. Direct investigation of the influence of isomerization at Asp-109 on oligomeric assembly is therefore not feasible in the absence of whole-protein synthesis. Nevertheless, the MD results show that the major consequence of l-Asp isomerization is disruption of the salt bridge with Arg-120. This outcome can be mimicked with a D109A mutant, where the acidic partner in the salt bridge has been removed. Native MS experiments with this mimic revealed oligomeric assemblies larger than those observed with the WT protein and a lower preference for even stoichiometries (Fig. 7C). Complementary results were also obtained by light-scattering experiments that showed a significantly increased propensity for aggregation of D109A relative to the WT (see Fig. S4). These results are consistent with trends observed for the R120G variant, in which the same salt bridge is disrupted (30). In both cases, the dimer interface is weakened and oligomer size increases. This may explain why the l-isoAsp variant is only observed in appreciable amounts in the insoluble fraction obtained from lenses (see Fig. 2E). Overall, the results in Fig. 7 confirm that subtle changes that mimic isomerization can impact oligomerization toward larger or smaller sizes even in the context of the full-length proteins.
Conclusion
Isomerization and epimerization are prevalent PTMs in long-lived proteins such as the crystallins found in the eye lens. Although these modifications are difficult to detect and cannot be probed by site-directed mutagenesis, we have demonstrated that they can cause significant structural perturbation and loss-of-function. Epimerization of a single serine residue is sufficient to inhibit noncovalent recognition needed to maintain proper interface strengths and dynamics. Furthermore, epimerization of serine or isomerization of nearby residues alters phosphorylation and any functionality derived from it. By redirecting and altering the peptide backbone, aspartic acid isomerization can also inhibit kinase recognition and disrupt native salt-bridge interactions, leading to improper oligomer assembly and size.
These observations show that what might appear to be innocuous PTMs can disrupt protein structure. It is possible to detect these modifications if they are present at 1% relative abundance to the unmodified canonical peptide (64). Given that long-lived proteins are also associated with many other diseases, including Alzheimer's and Parkinson's (1, 65, 66), it is likely that many of the structural issues highlighted herein also contribute to loss-of-function in these pathologies. The spontaneous nature of isomerization and epimerization dictates that repair will be unrealistic in most cases, suggesting that the best strategy for avoiding loss-of-function due to such modifications would be increasing protein turnover to prevent their occurrence in the first place.
Materials and methods
Protein expression and purification
Core αB (cABC, residues 68–153) was expressed in E. coli and purified as described previously (54). A gene insert encoding core αA (cAAC, residues 59–153) was purchased from Integrated DNA Technologies and inserted into a pET28a vector linearized with BamHI and XhoI (New England Biolabs) using an In-Fusion HD cloning kit (New England Biolabs) to generate a tobacco etch virus–cleavable His-tagged construct. This was expressed and purified in the same manner as cABC with addition of 5 mm BME in all buffers prior to size-exclusion chromatography, resulting in some population of BME-adducted protein visible in the spectra in Fig. 4. Core domains were stored in 100 mm NaCl, 20 mm Tris, pH 8, at −80 °C until use. Full-length αB was expressed and purified as described previously (54). Mutations S59D and D109A were introduced using a QuikChange site-directed mutagenesis kit (Agilent), and mutants were expressed and purified in the same manner as WT. Full-length proteins were stored in MS buffer (200 mm ammonium acetate, pH 6.9) at −20 °C until use. Concentrations were determined by UV absorbance at 280 nm.
Native MS of core domains and peptides
Spectra were collected using a previously described protocol (67) on a Synapt G1 IM-QToF mass spectrometer (Waters) with parameters as follows: capillary 1.5 kV, sampling cone 40 V, extraction cone 3 V, backing pressure 3.1 mbar, trap gas (argon) 3 ml min−1, trap cell voltage 10 V, transfer cell voltage 8 V. Ion mobility was enabled with parameters in the mobility cell: IMS gas flow 22 ml min−1, IMS wave velocity 320 m s−1, IMS wave height 5.5 V. Proteins were buffer exchanged into 200 mm ammonium acetate, pH 6.9, using a Biospin-6 column (Bio-Rad). All spectra were recorded at 10 μm based on concentration measurement post-buffer exchange. Samples were introduced using gold-coated capillaries prepared in-house. Lyophilized peptides-Ct (ERAIPVSRE) and G-Ct-G (GERAIPVSREG) with l- or d-Ser- were resuspended in milliQ H2O to a stock concentration of 1 mm and then diluted in MS buffer and mixed with protein immediately prior to analysis to a final concentration of 40 μm each for competition experiments. For quantitation, monomeric species were extracted in DriftScope (Waters) and intensities recorded from MassLynx using all resolved adduct peaks in addition to apo for 5+, 6+, and 7+ charge states. Data are reported as the mean ± S.D. for three replicates.
Native MS of full-length αB and mutants
Spectra were collected on a modified QExactive hybrid quadrupole-Orbitrap mass spectrometer (ThermoFisher Scientific) optimized for transmission of high-mass complexes (68). Protein concentration was 15 μm by monomer. Capillary voltage was 1.4 kV in positive ion mode with source temperature 200 °C and S-lens RF 200%. UHV pressure (argon) was between 1.4 × 10−9 and 1.7 × 10−9 mbar. In-source trapping fragmentation voltage ranged from −150 to −180 V. Ion transfer optics were as follows: injection flatapole 10 V, inter-flatapole lens 8 V, bent flatapole 6 V, transfer multipole 4 V, C-trap entrance lens 3 V. Nitrogen was used in the HCD cell and HCD energy was 0 V for intact spectra and tuned for optimal dissociation of each protein for CID spectra, ranging from 200 to 230 V. Resolution was kept at 17,500 at m/z = 200 for a transient time of 64 ms and the noise threshold was set to 3. For CID spectra, groupings of 30 microscans were combined to improve signal quality. Data were visualized using Xcalibur (ThermoFisher Scientific) and calibrated manually according to expected peak positions for WT αB-crystallin. Calibrated CID data were processed using UniDec software, which allowed for stoichiometric assignment and post-hoc correction for dissociated subunits (62).
Molecular modeling
To study the effect of Asp-109 epimerization, we extracted structures from PDB 2WJ7, which features the αB-crystallin core dimer in the Aβ II register (thus enabling the formation of the Asp-109–Arg-120 salt bridge). Three models featuring d-Asp, d-isoAsp, and l-isoAsp at position 109 in one of the two monomers, respectively, were produced by modifying PDB 2WJ7 in Schrödinger Maestro. Simulation parameters for nonstandard amino acids were produced with Antechamber (69, 70). All atom types were assigned according to available ff14SB parameters. Calculations were performed using the Amber ff14SB force field (71) on the NAMD molecular dynamics engine (72). Structures were first solvated in a box of TIP3P water, their box charge neutralized by addition of Na+ ions, and the resulting systems energy-minimized with 2000 conjugate gradient steps. We then performed 0.5-ns steps in the NPT ensemble, with all protein α-carbons constrained by a harmonic potential. Langevin dynamics were used to impose a temperature of 300 K, using a damping of 1/ps. A constant pressure of 1 atm was imposed via a Langevin piston having a period of 200 fs and a decay of 50 fs. The system was then further equilibrated in the NVT ensemble for 1 ns, after which 200-ns production runs in the NPT ensemble were performed. In all simulation steps, Particle Mesh Ewald was used to treat long-range electrostatic interactions, with a cutoff distance of 12 Å for van der Waals interactions, and a 2-fs time step was implemented by restraining every covalent bond with SHAKE.
His-111–Arg-123 and Asp-109–Arg-120 distances were measured every 100 ps. For the latter, we report the shortest distance between each of the hydrogens of Arg-120 guanidinium, and oxygens of Asp-109 carboxylate.
Author contributions
Y. A. L., M. P. C., D. L. R., M. T. D., J. L. P. B., and R. R. J. conceptualization; M. P. C., J. L. P. B., and R. R. J. funding acquisition; Y. A. L., M. P. C., D. L. R., and M. T. D. investigation and formal analysis; Y. A. L., J. L. P. B., and R. R. J. writing-original draft; J. L. P. B. and R. R. J. project administration; Y. A. L., M. P. C., D. L. R., M. T. D., J. L. P. B., and R. R. J. writing-review and editing.
Supplementary Material
Acknowledgments
We thank Frances Kondrat and Gillian Hilton (then at University of Oxford) for initial mutagenesis work.
This work was supported by National Institutes of Health Grant R01GM107099 from NIGMS (to R. R. J.), Oxford University Press Clarendon Award (to M. P. C.), and Engineering and Physical Sciences Research Council Grants EP/P016499/1 (to M. T. D.) and EP/J01835X/1 (to J. L. P. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
This article was chosen as one of our Editors' Picks.
This article contains Figs. S1–S4, Tables S1–S5, supporting Materials and methods, and supporting Refs. 1–12.
- PTM
- post-translational modification
- PDB
- Protein Data Bank
- MD
- molecular dynamics
- CID
- collision-induced dissociation
- WI
- water-insoluble
- WS
- water-soluble
- BME
- β-mercaptoethanol
- RDD-MS
- radical-directed dissociation-mass spectrometry.
References
- 1. Truscott R. J. W., Schey K. L., and Friedrich M. G. (2016) Old proteins in man: a field in its infancy. Trends Biochem. Sci. 41, 654–664 10.1016/j.tibs.2016.06.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Catterall J. B., Barr D., Bolognesi M., Zura R. D., and Kraus V. B. (2009) Post-translational aging of proteins in osteoarthritic cartilage and synovial fluid as measured by isomerized aspartate. Arthritis Res. Ther. 11, R55 10.1186/ar2675 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Truscott R. J., and Friedrich M. G. (2016) The etiology of human age-related cataract. proteins don't last forever. Biochim. Biophys. Acta 1860, 192–198 10.1016/j.bbagen.2015.08.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Hooi M. Y., and Truscott R. J. (2011) Racemisation and human cataract. d-Ser, d-Asp/Asn and d-Thr are higher in the lifelong proteins of cataract lenses than in age-matched normal lenses. Age (Dordr.) 33, 131–141 10.1007/s11357-010-9171-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Geiger T., and Clarke S. (1987) Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J. Biol. Chem. 262, 785–794 [PubMed] [Google Scholar]
- 6. Yamamoto A., Takagi H., Kitamura D., Tatsuoka H., Nakano H., Kawano H., Kuroyanagi H., Yahagi Y., Kobayashi S., Koizumi K., Sakai T., Saito K., Chiba T., Kawamura K., Suzuki K., et al. (1998) Deficiency in protein l-isoaspartyl methyltransferase results in a fatal progressive epilepsy. J. Neurosci. 18, 2063–2074 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Qin Z., Dimitrijevic A., and Aswad D. W. (2015) Accelerated protein damage in brains of PIMT+/− mice; a possible model for the variability of cognitive decline in human aging. Neurobiol. Aging 36, 1029–1036 10.1016/j.neurobiolaging.2014.10.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Hooi M. Y., Raftery M. J., and Truscott R. J. (2013) Age-dependent racemization of serine residues in a human chaperone protein. Protein Sci. 22, 93–100 10.1002/pro.2191 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Ni W., Dai S., Karger B. L., and Zhou Z. S. (2010) Analysis of isoaspartic acid by selective proteolysis with Asp-N and electron transfer dissociation mass spectrometry. Anal. Chem. 82, 7485–7491 10.1021/ac101806e [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Jansson E. T. (2018) Strategies for analysis of isomeric peptides. J. Sep. Sci. 41, 385–397 10.1002/jssc.201700852 [DOI] [PubMed] [Google Scholar]
- 11. Noguchi S., Miyawaki K., and Satow Y. (1998) Succinimide and isoaspartate residues in the crystal structures of hen egg-white lysozyme complexed with tri-N-acetylchitotriose. J. Mol. Biol. 278, 231–238 10.1006/jmbi.1998.1674 [DOI] [PubMed] [Google Scholar]
- 12. Noguchi S. (2010) Structural changes induced by the deamidation and isomerization of asparagine revealed by the crystal structure of Ustilago sphaerogena ribonuclease U2B. Biopolymers 93, 1003–1010 10.1002/bip.21514 [DOI] [PubMed] [Google Scholar]
- 13. Rehder D. S., Chelius D., McAuley A., Dillon T. M., Xiao G., Crouse-Zeineddini J., Vardanyan L., Perico N., Mukku V., Brems D. N., Matsumura M., and Bondarenko P. V. (2008) Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin γ2 antibody highlights the role avidity plays in antibody activity. Biochemistry 47, 2518–2530 10.1021/bi7018223 [DOI] [PubMed] [Google Scholar]
- 14. Zigler J. S. Jr., and Goosey J. (1981) Aging of protein molecules: lens crystallins as a model system. Trends Biochem. Sci. 6, 133–136 10.1016/0968-0004(81)90050-5 [DOI] [Google Scholar]
- 15. Fujii N., Takata T., Fujii N., and Aki K. (2016) Isomerization of aspartyl residues in crystallins and its influence upon cataract. Biochim. Biophys. Acta 1860, 183–191 10.1016/j.bbagen.2015.08.001 [DOI] [PubMed] [Google Scholar]
- 16. Takata T., and Fujii N. (2016) Isomerization of Asp residues plays an important role in αA-crystallin dissociation. FEBS J. 283, 850–859 10.1111/febs.13635 [DOI] [PubMed] [Google Scholar]
- 17. Lyon Y. A., Sabbah G. M., and Julian R. R. (2018) Differences in α-crystallin isomerization reveal the activity of protein isoaspartyl methyltransferase (PIMT) in the nucleus and cortex of human lenses. Exp. Eye Res. 171, 131–141 10.1016/j.exer.2018.03.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Masters P. M., Bada J. L., and Zigler J. S. (1978) Aspartic acid racemization in heavy molecular weight crystallins and water insoluble protein from normal human lenses and cataracts. Proc. Natl. Acad. Sci. U.S.A. 75, 1204–1208 10.1073/pnas.75.3.1204 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Horwitz J. (1992) α-Crystallin can function as a molecular chaperone. Proc. Natl. Acad. Sci. U.S.A. 89, 10449–10453 10.1073/pnas.89.21.10449 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Boelens W. C. (2014) Cell biological roles of αB-crystallin. Prog. Biophys. Mol. Biol. 115, 3–10 10.1016/j.pbiomolbio.2014.02.005 [DOI] [PubMed] [Google Scholar]
- 21. Horwitz J., Bova M. P., Ding L. L., Haley D. A., and Stewart P. L. (1999) Lens α-crystallin: function and structure. Eye 13, 403–408 10.1038/eye.1999.114 [DOI] [PubMed] [Google Scholar]
- 22. Iwaki T., Kume-Iwaki A., and Goldman J. E. (1990) Cellular distribution of αB-crystallin in non-lenticular tissues. J. Histochem. Cytochem. 38, 31–39 10.1177/38.1.2294148 [DOI] [PubMed] [Google Scholar]
- 23. Bennardini F., Wrzosek A., and Chiesi M. (1992) αB-crystallin in cardiac tissue: association with actin and desmin filaments. Circ. Res. 71, 288–294 10.1161/01.RES.71.2.288 [DOI] [PubMed] [Google Scholar]
- 24. Iwaki T., Wisniewski T., Iwaki A., Corbin E., Tomokane N., Tateishi J., and Goldman J. E. (1992) Accumulation of αB-crystallin in central nervous system glia and neurons in pathologic conditions. Am. J. Pathol. 140, 345–356 [PMC free article] [PubMed] [Google Scholar]
- 25. Renkawek K., Voorter C. E., Bosman G. J., van Workum F. P., and de Jong W. W. (1994) Expression of αB-crystallin in Alzheimer's disease. Acta Neuropathol. 87, 155–160 10.1007/BF00296185 [DOI] [PubMed] [Google Scholar]
- 26. Caspers G. J., Leunissen J. A., and de Jong W. W. (1995) The expanding small heat-shock protein family, and structure predictions of the conserved “α-crystallin domain.” J. Mol. Evol. 40, 238–248 [DOI] [PubMed] [Google Scholar]
- 27. Hochberg G. K., and Benesch J. L. P. (2014) Dynamical structure of αB-crystallin. Prog. Biophys. Mol. Biol. 115, 11–20 10.1016/j.pbiomolbio.2014.03.003 [DOI] [PubMed] [Google Scholar]
- 28. Haslbeck M., Peschek J., Buchner J., and Weinkauf S. (2016) Structure and function of α-crystallins: Traversing from in vitro to in vivo. Biochim. Biophys. Acta 1860, 149–166 10.1016/j.bbagen.2015.06.008 [DOI] [PubMed] [Google Scholar]
- 29. Basha E., O'Neill H., and Vierling E. (2012) Small heat shock proteins and α-crystallins: dynamic proteins with flexible functions. Trends Biochem. Sci. 37, 106–117 10.1016/j.tibs.2011.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Bova M. P., Yaron O., Huang Q., Ding L., Haley D. A., Stewart P. L., and Horwitz J. (1999) Mutation R120G in B-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function. Proc. Natl. Acad. Sci. 96, 6137–6142 10.1073/pnas.96.11.6137 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Clark A. R., Lubsen N. H., and Slingsby C. (2012) SHSP in the eye lens: crystallin mutations, cataract and proteostasis. Int. J. Biochem. Cell Biol. 44, 1687–1697 10.1016/j.biocel.2012.02.015 [DOI] [PubMed] [Google Scholar]
- 32. Kato K., Inaguma Y., Ito H., Iida K., Iwamoto I., Kamei K., Ochi N., Ohta H., and Kishikawa M. (2001) Ser-59 is the major phosphorylation site in αB-crystallin accumulated in the brains of patients with Alexander's disease. J. Neurochem. 76, 730–736 [DOI] [PubMed] [Google Scholar]
- 33. Maddala R., and Rao V. P. (2005) α-Crystallin localizes to the leading edges of migrating lens epithelial cells. Exp. Cell Res. 306, 203–215 10.1016/j.yexcr.2005.01.026 [DOI] [PubMed] [Google Scholar]
- 34. Aquilina J. A., Benesch J. L. P., Ding L. L., Yaron O., Horwitz J., and Robinson C. V. (2004) Phosphorylation of αB-crystallin alters chaperone function through loss of dimeric substructure. J. Biol. Chem. 279, 28675–28680 10.1074/jbc.M403348200 [DOI] [PubMed] [Google Scholar]
- 35. Ecroyd H., Meehan S., Horwitz J., Aquilina J. A., Benesch J. L. P., Robinson C. V., Macphee C. E., and Carver J. A. (2007) Mimicking phosphorylation of αB-crystallin affects its chaperone activity. Biochem. J. 401, 129–141 10.1042/BJ20060981 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Li R., and Reiser G. (2011) Phosphorylation of Ser45 and Ser59 of αb-crystallin and p38/extracellular regulated kinase activity determine αb-crystallin-mediated protection of rat brain astrocytes from C2-ceramide- and staurosporine-induced cell death. J. Neurochem. 118, 354–364 10.1111/j.1471-4159.2011.07317.x [DOI] [PubMed] [Google Scholar]
- 37. Chandler S. A., and Benesch J. L. P. (2018) Mass spectrometry beyond the native state. Curr. Opin. Chem. Biol. 42, 130–137 10.1016/j.cbpa.2017.11.019 [DOI] [PubMed] [Google Scholar]
- 38. Li H., Sheng Y., McGee W., Cammarata M., Holden D., and Loo J. A. (2017) Structural characterization of native proteins and protein complexes by electron ionization dissociation–mass spectrometry. Anal. Chem. 89, 2731–2738 10.1021/acs.analchem.6b02377 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Tao Y., and Julian R. R. (2014) Identification of amino acid epimerization and isomerization in crystallin proteins by tandem LC-MS. Anal. Chem. 86, 9733–9741 10.1021/ac502296c [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Riggs D. L., Gomez S. V., and Julian R. R. (2017) Sequence and solution effects on the prevalence of d-isomers produced by deamidation. ACS Chem. Biol. 12, 2875–2882 10.1021/acschembio.7b00686 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Laganowsky A., Benesch J. L. P., Landau M., Ding L., Sawaya M. R., Cascio D., Huang Q., Robinson C. V., Horwitz J., and Eisenberg D. (2010) Crystal structures of truncated αA and αB crystallins reveal structural mechanisms of polydispersity important for eye lens function. Protein Sci. 19, 1031–1043 10.1002/pro.380 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Hilton G. R., Hochberg G. K., Laganowsky A., McGinnigle S. I., Baldwin A. J., and Benesch J. L. P. (2013) C-terminal interactions mediate the quaternary dynamics of αB-crystallin. Philos. Trans. R. Soc. Lond. B Biol. Sci. 368, 20110405 10.1098/rstb.2011.0405 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Delbecq S. P., Jehle S., and Klevit R. (2012) Binding determinants of the small heat shock protein, αB-crystallin: recognition of the “IxI” motif. EMBO J. 31, 4587–4594 10.1038/emboj.2012.318 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. El-Hawiet A., Kitova E. N., Liu L., and Klassen J. S. (2010) Quantifying labile protein-ligand interactions using electrospray ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 21, 1893–1899 [DOI] [PubMed] [Google Scholar]
- 45. Tardieu A. (1998) α-Crystallin quaternary structure and interactive properties control eye lens transparency. Int. J. Biol. Macromol. 22, 211–217 10.1016/S0141-8130(98)00018-X [DOI] [PubMed] [Google Scholar]
- 46. Jehle S., Rajagopal P., Bardiaux B., Markovic S., Kühne R., Stout J. R., Higman V. A., Klevit R. E., van Rossum B. J., and Oschkinat H. (2010) Solid-state NMR and SAXS studies provide a structural basis for the activation of αb-crystallin oligomers. Nat. Struct. Mol. Biol. 17, 1037–1042 10.1038/nsmb.1891 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Bakthisaran R., Akula K. K., Tangirala R., and Rao Ch. M. (2016) Phosphorylation of αB-crystallin: role in stress, aging and patho-physiological conditions. Biochim. Biophys. Acta 1860, 167–182 10.1016/j.bbagen.2015.09.017 [DOI] [PubMed] [Google Scholar]
- 48. Grey A. C., and Schey K. L. (2008) Distribution of bovine and rabbit lens α-crystallin products by MALDI imaging mass spectrometry. Mol. Vis. 14, 171–179 [PMC free article] [PubMed] [Google Scholar]
- 49. Kato K., Ito H., Kamei K., Inaguma Y., Iwamoto I., and Saga S. (1998) Phosphorylation of αB-crystallin in mitotic cells and identification of enzymatic activities responsible for phosphorylation. J. Biol. Chem. 273, 28346–28354 10.1074/jbc.273.43.28346 [DOI] [PubMed] [Google Scholar]
- 50. McFadden P. N., Lou L. L., Drickamer K., and Clarke S. (1987) The stereospecificity of protein kinases. Arch. Biochem. Biophys. 259, 227–233 10.1016/0003-9861(87)90490-5 [DOI] [PubMed] [Google Scholar]
- 51. Braun N., Zacharias M., Peschek J., Kastenmüller A., Zou J., Hanzlik M., Haslbeck M., Rappsilber J., Buchner J., and Weinkauf S. (2011) Multiple molecular architectures of the eye lens chaperone B-crystallin elucidated by a triple hybrid approach. Proc. Natl. Acad. Sci. U.S.A. 108, 20491–20496 10.1073/pnas.1111014108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Ahmad M. F., Raman B., Ramakrishna T., and Rao Ch. M. (2008) Effect of phosphorylation on αB-crystallin: differences in stability, subunit exchange and chaperone activity of homo- and mixed oligomers of αB-crystallin and its phosphorylation-mimicking mutant. J. Mol. Biol. 375, 1040–1051 10.1016/j.jmb.2007.11.019 [DOI] [PubMed] [Google Scholar]
- 53. Clark A. R., Naylor C. E., Bagnéris C., Keep N. H., and Slingsby C. (2011) Crystal structure of R120G disease mutant of human αB-crystallin domain dimer shows closure of a groove. J. Mol. Biol. 408, 118–134 10.1016/j.jmb.2011.02.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Hochberg G. K., Ecroyd H., Liu C., Cox D., Cascio D., Sawaya M. R., Collier M. P., Stroud J., Carver J. A., Baldwin A. J., Robinson C. V., Eisenberg D. S., Benesch J. L. P., and Laganowsky A. (2014) The structured core domain of B-crystallin can prevent amyloid fibrillation and associated toxicity. Proc. Natl. Acad. Sci. U.S.A. 111, E1562–E1570 10.1073/pnas.1322673111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Simon S., Michiel M., Skouri-Panet F., Lechaire J. P., Vicart P., and Tardieu A. (2007) Residue R120 is essential for the quaternary structure and functional integrity of human αB-crystallin. Biochemistry 46, 9605–9614 10.1021/bi7003125 [DOI] [PubMed] [Google Scholar]
- 56. Michiel M., Skouri-Panet F., Duprat E., Simon S., Férard C., Tardieu A., and Finet S. (2009) Abnormal assemblies and subunit exchange of αB-crystallin R120 mutants could be associated with destabilization of the dimeric substructure. Biochemistry 48, 442–453 10.1021/bi8014967 [DOI] [PubMed] [Google Scholar]
- 57. Vicart P., Caron A., Guicheney P., Li Z., Prévost M. C., Faure A., Chateau D., Chapon F., Tomé F., Dupret J. M., Paulin D., and Fardeau M. (1998) A missense mutation in the αb-crystallin chaperone gene causes a desmin-related myopathy. Nat. Genet. 20, 92–95 10.1038/1765 [DOI] [PubMed] [Google Scholar]
- 58. Fichna J. P., Potulska-Chromik A., Miszta P., Redowicz M. J., Kaminska A. M., Zekanowski C., and Filipek S. (2017) A novel dominant D109A CRYAB mutation in a family with myofibrillar myopathy affects αB-crystallin structure. BBA Clin. 7, 1–7 10.1016/j.bbacli.2016.11.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Brodehl A., Gaertner-Rommel A., Klauke B., Grewe S. A., Schirmer I., Peterschröder A., Faber L., Vorgerd M., Gummert J., Anselmetti D., Schulz U., Paluszkiewicz L., and Milting H. (2017) The novel αB-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy. Hum. Mutat. 38, 947–952 10.1002/humu.23248 [DOI] [PubMed] [Google Scholar]
- 60. Mainz A., Bardiaux B., Kuppler F., Multhaup G., Felli I. C., Pierattelli R., and Reif B. (2012) Structural and mechanistic implications of metal binding in the small heat-shock protein αB-crystallin. J. Biol. Chem. 287, 1128–1138 10.1074/jbc.M111.309047 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Aquilina J. A., Benesch J. L. P., Bateman O. A., Slingsby C., and Robinson C. V. (2003) Polydispersity of a mammalian chaperone: mass spectrometry reveals the population of oligomers in αB-crystallin. Proc. Natl. Acad. Sci. U.S.A. 100, 10611–10616 10.1073/pnas.1932958100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Marty M. T., Baldwin A. J., Marklund E. G., Hochberg G. K., Benesch J. L. P., and Robinson C. V. (2015) Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles. Anal. Chem. 87, 4370–4376 10.1021/acs.analchem.5b00140 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Ciano M., Allocca S., Ciardulli M. C., Della Volpe L., Bonatti S., and D'Agostino M. (2016) Differential phosphorylation-based regulation of αB-crystallin chaperone activity for multipass transmembrane proteins. Biochem. Biophys. Res. Commun. 479, 325–330 10.1016/j.bbrc.2016.09.071 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Lyon Y. A., Sabbah G. M., and Julian R. R. (2017) Identification of sequence similarities among isomerization hotspots in crystallin proteins. J. Proteome Res. 16, 1797–1805 10.1021/acs.jproteome.7b00073 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Savas J. N., Toyama B. H., Xu T., Yates J. R. 3rd., and Hetzer M. W. (2012) Extremely long-lived nuclear pore proteins in the rat brain. Science 335, 942 10.1126/science.1217421 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Ben-Zvi A., Miller E. A., and Morimoto R. I. (2009) Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc. Natl. Acad. Sci. U.S.A. 106, 14914–14919 10.1073/pnas.0902882106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Kondrat F. D., Struwe W. B., and Benesch J. L. P. (2015) Native mass spectrometry: towards high-throughput structural proteomics. Methods Mol. Biol. 1261, 349–371 [DOI] [PubMed] [Google Scholar]
- 68. Rose R. J., Damoc E., Denisov E., Makarov A., and Heck A. J. (2012) High-sensitivity Orbitrap mass analysis of intact macromolecular assemblies. Nat. Methods 9, 1084–1086 10.1038/nmeth.2208 [DOI] [PubMed] [Google Scholar]
- 69. Wang J., Wang W., Kollman P. A., and Case D. A. (2006) Automatic atom type and bond type perception in molecular mechanical calculations. J. Mol. Graph. Model. 25, 247–260 10.1016/j.jmgm.2005.12.005 [DOI] [PubMed] [Google Scholar]
- 70. Wang J., Wolf R. M., Caldwell J. W., Kollman P. A., and Case D. A. (2004) Development and testing of a general Amber force field. J. Comput. Chem. 25, 1157–1174 10.1002/jcc.20035 [DOI] [PubMed] [Google Scholar]
- 71. Maier J. A., Martinez C., Kasavajhala K., Wickstrom L., Hauser K. E., and Simmerling C. (2015) ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696–3713 10.1021/acs.jctc.5b00255 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Phillips J. C., Braun R., Wang W., Gumbart J., Tajkhorshid E., Villa E., Chipot C., Skeel R. D., Kalé L., and Schulten K. (2005) Scalable molecular dynamics with NAMD. J. Comput. Chem. 26, 1781–1802 10.1002/jcc.20289 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.